Ketek Launch Is First For Sanofi-Aventis; Merger Will Test Focus
Executive Summary
Ketek will be the first product launch for the newly formed Sanofi-Aventis
You may also be interested in...
Acomplia Launch Could Come This Year, Sanofi-Aventis Says
Sanofi-Aventis' weight loss/smoking cessation agent Acomplia (rimonabant) could be launched as early as the end of the year, Exec VP-Pharmaceutical Operations Hanspeter Spek said
Acomplia Launch Could Come This Year, Sanofi-Aventis Says
Sanofi-Aventis' weight loss/smoking cessation agent Acomplia (rimonabant) could be launched as early as the end of the year, Exec VP-Pharmaceutical Operations Hanspeter Spek said
Ketek, Allegra Deserve Special Formulary Status – Aventis Consultants
The ketolide drug class should be added to the U.S. Pharmacopeia's model drug classification system as a unique pharmacologic class, Stephen Jenkins, PhD, Carolinas Medical Center said during an Aug. 27 public meeting on the proposed Medicare Rx formulary guidelines